Tepper, S. J., Ashina, M., Reuter, U., Hallström, Y., Broessner, G., Bonner, J. H., . . . Mikol, D. D. (2021). Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: Post-hoc analyses of episodic and chronic migraine clinical trials. BMC.
Dyfyniad Arddull ChicagoTepper, Stewart J., et al. Reduction in Acute Migraine-specific and Non-specific Medication Use in Patients Treated with Erenumab: Post-hoc Analyses of Episodic and Chronic Migraine Clinical Trials. BMC, 2021.
Dyfyniad MLATepper, Stewart J., et al. Reduction in Acute Migraine-specific and Non-specific Medication Use in Patients Treated with Erenumab: Post-hoc Analyses of Episodic and Chronic Migraine Clinical Trials. BMC, 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.